1. Верткин А.Л., Адонина Е.В., Галкин И.В. и др. Место блокаторов рецепторов ангиотензина в терапии артериальной гипертензии у пациентов с полипатией. Рус. мед. журн. 2009; 8.
2. World Sales IMS Data, 2007.
3. Wogen J et al. Patient adherence with amlodipine, lisinopril, or valsartan therapy in a usual-care setting. J Managed Care Pharm 2003; 9: 424-9.
4. Julius S et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet 2004; 363.
5. Cohn JN et al. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001; 345: 1667-75.
6. Pfeffer MA et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003; 349: 1893-906.
7. Neutel J et al. Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours. Clin Ther 1997; 19: 447-57.
8. Mclnnes GT et al. Angiotensin II antagonism in clinical practice: experience with valsartan. J Cardiovascular Pharmacol 1999; 33 (suppl 1): S29-S32.
9. Malacco E et al. Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study. Clin Ther 2004; 26(6): 855-65.
10. Malacco E et al. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study. Clin Ther 2003; 25(11): 2765-80.
11. Пушкарь Д.Ю., Верткин А.Л. Эректильная дисфункция: кардиологические аспекты. М.: Медпресс-информ, 2005.
Авторы
А.Л.Верткин, А.С.Скотников
Московский государственный медико-стоматологический университет